Seasonal chemoprevention as an effective malaria preventive strategy for children in the Sahel
Published:
Resources: Learning paper
This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel project.
This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) project, which was launched in 2015 to overcome barriers to seasonal malaria chemoprevention (SMC) scale-up. By supporting national malaria control/elimination programmes in Burkina Faso, Chad, Guinea, Mali, Niger, Nigeria and The Gambia, the project aimed to provide up to 30 million SMC treatments to 7.5 million under-fives annually. This required a rapid expansion of the global supply of quality-assured and child-friendly SMC treatments by significantly increasing predictable demand through feasible, acceptable and affordable implementation of SMC by national governments.
